Healthcare -
Biotechnology - NASDAQ - US
$ 9.94
7.81 %
$ 220 M
Market Cap
-4.56
P/E
INMB - OTHER CURRENT LIABILITIES
Other Current Liabilities INMB - INmune Bio, Inc.
524 K
LAST VALUE
12.78%
2 YEAR CAGR
14.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR